Association Between Anti-Müllerian Hormone and Early Spontaneous Abortion in Assisted Reproduction Treatment: A Case-Control Study Integrated with Biological Evidence
- PMID: 38228975
- DOI: 10.1007/s43032-023-01442-2
Association Between Anti-Müllerian Hormone and Early Spontaneous Abortion in Assisted Reproduction Treatment: A Case-Control Study Integrated with Biological Evidence
Abstract
Early spontaneous abortion (ESA) is a common adverse pregnancy outcome mainly attributed to embryo chromosomal abnormalities. However, as a quantitative marker, whether the anti-Müllerian hormone (AMH) can reflect oocyte quality is still controversial. By integrating biological evidence and adjusting many cofounders, this study aimed to clarify the controversies about the association between AMH and ESA caused by embryo aneuploidy during assisted reproductive technology (ART) treatment. We strictly preselected 988 patients receiving first ART treatment for analyzing clinical data, while 55 of them acquired chorionic villi karyotype results. In addition, 373 biopsied embryos from 126 patients receiving preimplantation genetic diagnosis (PGT) were tracked to compare embryo karyotypes. Univariate and multiple factor regressions were applied to analyze the risk factors leading to ESA. As covariates unadjusted, AMH (odds ratio 0.87, 95% CI 0.82-0.93) was the significant variable contributing to ESA. However, AMH played no significant role in the following regression models after age was adjusted. Also, AMH had no significant association with ESA in most age-adjusted subgroups, except in the male factors engaged subgroup. Additionally, compared to the patients with euploid chorionic villi karyotypes, those with aneuploid karyotypes were older and acquired fewer oocytes, yet their AMH levels were not significantly different. Furthermore, the embryo aneuploidy was independent of AMH while associated with maternal age, retrieved oocyte number, and embryo quality. This study suggested that AMH was unassociated with the ESA caused by embryo aneuploidy in ART therapy. As a critical cofounder, age remains the variable closely related to ESA.
Keywords: Anti-Müllerian hormone; Assisted reproductive technology; Early spontaneous abortion; Embryonic karyotype.
© 2024. The Author(s), under exclusive licence to Society for Reproductive Investigation.
Similar articles
-
AMH independently predicts aneuploidy but not live birth per transfer in IVF PGT-A cycles.Reprod Biol Endocrinol. 2023 Feb 4;21(1):19. doi: 10.1186/s12958-023-01066-w. Reprod Biol Endocrinol. 2023. PMID: 36739415 Free PMC article.
-
Low anti-Müllerian hormone concentration is associated with increased risk of embryonic aneuploidy in women of advanced age.Reprod Biomed Online. 2018 Aug;37(2):178-183. doi: 10.1016/j.rbmo.2018.04.039. Epub 2018 Apr 13. Reprod Biomed Online. 2018. PMID: 29724534
-
Diminished ovarian reserve and poor response to stimulation in patients <38 years old: a quantitative but not qualitative reduction in performance.Hum Reprod. 2018 Aug 1;33(8):1489-1498. doi: 10.1093/humrep/dey238. Hum Reprod. 2018. PMID: 30010882
-
Anti-Müllerian Hormone and Its Predictive Utility in Assisted Reproductive Technologies Outcomes.Clin Obstet Gynecol. 2019 Jun;62(2):238-256. doi: 10.1097/GRF.0000000000000436. Clin Obstet Gynecol. 2019. PMID: 30994481 Review.
-
Preimplantation genetic testing in assisted reproduction technology.J Gynecol Obstet Hum Reprod. 2020 May;49(5):101723. doi: 10.1016/j.jogoh.2020.101723. Epub 2020 Feb 26. J Gynecol Obstet Hum Reprod. 2020. PMID: 32113002 Review.
References
-
- Magnus MC, Wilcox AJ, Morken NH, Weinberg CR, Håberg SE. Role of maternal age and pregnancy history in risk of miscarriage: prospective register based study. BMJ. 2019;364:l869. https://doi.org/10.1136/bmj.l869 . - DOI - PubMed - PMC
-
- Frederiksen LE, Ernst A, Brix N, Braskhøj Lauridsen LL, Roos L, Ramlau-Hansen CH, et al. Risk of adverse pregnancy outcomes at advanced maternal age. Obstet Gynecol. 2018;131(3):457–63. https://doi.org/10.1097/AOG.0000000000002504 . - DOI - PubMed
-
- Pinheiro RL, Areia AL, Mota Pinto A, Donato H. Advanced maternal age: adverse outcomes of pregnancy, a meta-analysis. Acta Med Port. 2019;32:219–26. https://doi.org/10.20344/amp.11057 . - DOI - PubMed
-
- Lean SC, Derricott H, Jones RL, Heazell AEP. Advanced maternal age and adverse pregnancy outcomes: a systematic review and meta-analysis. PLoS One. 2017;12:e0186287. https://doi.org/10.1371/journal.pone.0186287 . - DOI - PubMed - PMC
-
- Garrido-Gimenez C, Alijotas-Reig J. Recurrent miscarriage: causes, evaluation and management. Postgrad Med J. 2015;91:151–62. https://doi.org/10.1136/postgradmedj-2014-132672 . - DOI - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials